imatinib mesylate has been researched along with Dyspnea in 9 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 4 (44.44) | 29.6817 |
| 2010's | 5 (55.56) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Beghini, A; Cassin, R; Cortelezzi, A; Ferla, V; Fracchiolla, NS; Gianelli, U; Gottardi, E; Iurlo, A; Spinelli, O | 1 |
| Adachi, S; Hirashiki, A; Kondo, T; Matsubara, H; Miyaji, K; Murohara, T; Nakaguro, M; Ogawa, A; Yokoi, T | 1 |
| Cuthbert, RJ; Furby, D; McMullin, MF; McNicholl, F; Ramanujam, D; Richardson, D | 1 |
| Daniels, CE; Gabor, E; Lasky, JA; Limper, AH; Mieras, K; Schroeder, DR | 1 |
| Cheung, WY; Ksienski, D | 1 |
| Anastasi, J; Hossain, NM; Jain, N; McConville, JF; Odenike, O; Steinmetz, JL | 1 |
| Audring, H; Baskaynak, G; Dörken, B; Kreuzer, KA; le Coutre, P; Riess, H; Schwarz, M; Zuber, J | 1 |
| Curtin, PT; Druker, BJ; Leis, JF; Maziarz, RT; Primack, SL; Schubach, SE | 1 |
| Phatak, PD; Rajda, J | 1 |
1 trial(s) available for imatinib mesylate and Dyspnea
| Article | Year |
|---|---|
Imatinib treatment for idiopathic pulmonary fibrosis: Randomized placebo-controlled trial results.
Topics: Aged; Anemia; Benzamides; Disease Progression; Double-Blind Method; Dyspnea; Feasibility Studies; Female; Follow-Up Studies; Gastrointestinal Diseases; Hematoma, Subdural; Humans; Idiopathic Pulmonary Fibrosis; Imatinib Mesylate; Leukopenia; Male; Middle Aged; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Respiratory Function Tests; Survival Analysis; Treatment Outcome | 2010 |
8 other study(ies) available for imatinib mesylate and Dyspnea
| Article | Year |
|---|---|
Successful treatment with imatinib in a patient with chronic eosinophilic leukemia not otherwise specified.
Topics: Antineoplastic Agents; Benzamides; Dyspnea; Humans; Hypereosinophilic Syndrome; Imatinib Mesylate; Leukemia; Male; Middle Aged; Muscle Weakness; Piperazines; Pyrimidines; Sweating | 2014 |
Imatinib is partially effective for the treatment of pulmonary capillary hemangiomatosis.
Topics: Adult; Antihypertensive Agents; Antineoplastic Agents; Autopsy; Benzamides; Bosentan; Cardiac Catheterization; Dyspnea; Echocardiography; Epoprostenol; Fatal Outcome; Hemangioma, Capillary; Humans; Hypertension, Pulmonary; Imatinib Mesylate; Lung; Lung Neoplasms; Male; Piperazines; Purines; Pyrimidines; Radiography, Thoracic; Sildenafil Citrate; Sulfonamides; Treatment Failure | 2014 |
Dramatic resolution of respiratory symptoms with imatinib mesylate in patients with chronic myeloid leukemia presenting with lower airway symptoms resembling asthma.
Topics: Adult; Antineoplastic Agents; Asthma, Exercise-Induced; B-Lymphocytes; Benzamides; Cough; Diagnostic Errors; Dyspnea; Exercise; Humans; Imatinib Mesylate; Leukemia, Myeloid, Chronic-Phase; Leukotriene C4; Male; Paraneoplastic Syndromes; Piperazines; Protein Kinase Inhibitors; Pyrimidines; Remission Induction | 2009 |
Metastatic uterine leiomyosarcoma and eosinophilia.
Topics: Antineoplastic Agents; Benzamides; Dyspnea; Eosinophilia; Fatal Outcome; Female; Humans; Hydroxyurea; Imatinib Mesylate; Leiomyosarcoma; Liver Neoplasms; Lung Neoplasms; Middle Aged; Piperazines; Prednisone; Pyrimidines; Splenic Neoplasms; Uterine Neoplasms | 2011 |
A 32-year-old man with persistent cough, shortness of breath, eosinophilic pneumonia, and peripheral blood eosinophilia. Myeloid neoplasm associated with eosinophilia and platelet-derived growth factor receptor-alpha rearrangement.
Topics: Adult; Antineoplastic Agents; Benzamides; Bone Marrow Neoplasms; Cough; Dyspnea; Eosinophilia; Gene Rearrangement; Humans; Imatinib Mesylate; Male; mRNA Cleavage and Polyadenylation Factors; Oncogene Proteins, Fusion; Piperazines; Pulmonary Eosinophilia; Pyrimidines; Receptor, Platelet-Derived Growth Factor alpha; Steroids; Treatment Outcome | 2012 |
Squamous cutaneous epithelial cell carcinoma in two CML patients with progressive disease under imatinib treatment.
Topics: Age Factors; Aged; Antineoplastic Agents; Benzamides; Carcinoma, Squamous Cell; Cocarcinogenesis; Coronary Disease; Drug Eruptions; Dyspnea; Enzyme Inhibitors; Facial Neoplasms; Humans; Hydroxyurea; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Male; Neoplasms, Radiation-Induced; Neoplasms, Second Primary; Pancytopenia; Piperazines; Pleural Effusion; Pyrimidines; Sunlight; Ultraviolet Rays | 2003 |
Management of life-threatening pulmonary leukostasis with single agent imatinib mesylate during CML myeloid blast crisis.
Topics: Aged; Antineoplastic Agents; Apoptosis; Benzamides; Blast Crisis; Dyspnea; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Leukostasis; Lung; Male; Piperazines; Pyrimidines; Remission Induction; Tomography, X-Ray Computed | 2004 |
Reversible drug-induced interstitial pneumonitis following imatinib mesylate therapy.
Topics: Aged; Antineoplastic Agents; Benzamides; Dyspnea; Female; Humans; Imatinib Mesylate; Leukemia, Myelogenous, Chronic, BCR-ABL Positive; Lung Diseases, Interstitial; Oxygen Inhalation Therapy; Piperazines; Pyrimidines; Radiography, Thoracic; Treatment Outcome | 2005 |